Weight Loss Drugs Show Potential Benefits for Cancer Patients
▸ Part of: Veterinary Laboratory in Dhangadhi Designated National Rabies Referral Laboratory
Medicines like Ozempic and Wegovy, used for weight loss and diabetes, are showing potential benefits for cancer patients by reducing the risk of cancer and increasing survival chances. These GLP-1 receptor agonists decrease inflammation and strengthen the immune system, which can help control blood sugar and slow cancer cell growth. While not a primary cancer treatment, they are expected to enhance the effectiveness of chemotherapy and radiation.
Read full article (2 min read) ›